Several animal and epidemiological studies have shown that disturbances in the in utero environment may programme the fetus for the development of adult diseases in later life(Reference Barker1, Reference Simmons2). In India, the prevalence of low birth weight due to maternal malnutrition and poor antenatal care continues to be a major public health problem. Further, the metabolic syndrome, recognised as a major determinant of diet-related chronic diseases (type 2 diabetes and CHD), is widely prevalent. Insulin resistance is the underlying feature of the metabolic syndrome. Although the mechanism involved in the fetal programming of adult diseases has remained unknown, recent evidence indicates that nutritional imbalances during pregnancy cause perturbation of prenatal development which in turn permanently alters the structure, function and metabolism of tissues and organs(Reference Holness, Langdown and Sugden3). Such alteration reduces fetal and postnatal growth resulting in increased susceptibility to diet-related diseases in adult life.
Dietary fatty acids are known to have effects on insulin sensitivity. Changing the fatty acid content of the diet potentially influences insulin action, with SFA decreasing insulin sensitivity and PUFA increasing insulin sensitivity(Reference Lichtenstein and Schwab4). Furthermore, PUFA and their metabolites regulate the expression of several genes involved in glucose and lipid metabolism(Reference Clarke5). Both linoleic acid (LA) and α-linolenic acid (ALA) and their long-chain PUFA derivatives are required during normal fetal development to support the synthesis of structural lipids of brain and retinal tissue(Reference Lauritzen, Hansen and Jørgensen6). Studies have documented that an increased intake of long-chain n-3 PUFA during pregnancy increases the length of gestation and birth size, indicating that maternal long-chain PUFA status during pregnancy is critical for the development of the fetus(Reference Olsen, Sørensen and Secher7).
Several animal models have been established to investigate the possible role of the fetal environment in determining future susceptibility to adult diseases and the underlying mechanism. These include maternal protein restriction(Reference Ozanne, Wang and Coleman8, Reference Fernandez-Twinn, Wayman and Ekizoglou9), maternal energy restriction(Reference Kind, Clifton and Grant10) and maternal mineral restriction(Reference Lewis, Petry and Ozanne11, Reference Venu, Kishore and Raghunath12) in the rat. However, the potential role of dietary fatty acids has not been fully explored. Studies have shown that maternal intake of a high-fat diet predisposes the offspring to development of the metabolic syndrome(Reference Buckley, Keserü and Briody13). Another study demonstrated that maternal intake of SFA predisposes the offspring to insulin resistance whereas long-chain n-3 PUFA had no effect(Reference Siemelink, Verhoef and Dormans14). Recent studies have shown that perinatal n-3 PUFA deficiency predisposes the offspring to hypertension in adult life(Reference Armitage, Pearce and Sinclair15). Further, postnatal n-3 fatty acid supplementation has been shown to prevent the adverse effects of maternal glucocorticoid exposure(Reference Wyrwoll, Mark and Mori16). In addition, maternal supplementation of long-chain n-3 PUFA to a diet containing marginal protein has been shown to be beneficial in maintaining circulating glucose, insulin, cholesterol and homocysteine levels in the adult offspring(Reference Joshi, Rao and Golwilkar17).
In recent years, the intake of n-6 PUFA and trans-fatty acids (TFA) has increased whereas n-3 PUFA intake has decreased. Studies on dietary fat intake among Indians showed that n-6 PUFA requirements are fully met owing to their high levels in cereal, millet and vegetable oils but n-3 PUFA intake is low and therefore the n-6:n-3 ratio is high(Reference Ghafoorunissa18). This change in dietary habits might be responsible for the increased prevalence of diet-related chronic diseases. Dietary n-3 PUFA has been shown to exert beneficial effects on insulin sensitivity and the development of type 2 diabetes(Reference Storlien, Jenkins and Chisholm19, Reference Nettleton and Katz20). A high intake of n-6 PUFA has been shown to have a negative impact on glucose metabolism and insulin sensitivity(Reference Storlien, Jenkins and Chisholm19). Further, in sucrose-induced insulin-resistant rats, we reported that substitution of dietary ALA (2·3 % energy (en%), n-6:n-3 ratio 2) or long-chain (n-3) PUFA (0·56 en%, n-6:n-3 ratio 10) for LA increased peripheral insulin sensitivity(Reference Ghafoorunissa, Ibrahim and Natarajan21, Reference Ghafoorunissa, Ibrahim and Rajkumar22). We also showed that both SFA and TFA decreased insulin sensitivity and, compared with SFA, TFA decreased the insulin sensitivity to a greater extent(Reference Natarajan, Ibrahim and Ghafoorunissa23, Reference Ibrahim, Natrajan and Ghafoorunissa24). TFA has been shown to inhibit PUFA biosynthesis resulting in a decreased formation of long-chain PUFA(Reference Larqué, García-Ruiz and Perez-Llamas25). In view of increasing interest in the role of long-chain PUFA during fetal and early development and the potential adverse effects of TFA on long-chain PUFA synthesis, there has been more concern on the intake of TFA during pregnancy(Reference Innis26). Although the role of dietary PUFA and TFA on insulin sensitivity in adult animals is clear, the effects during pregnancy are less explored. The aim of the present study was to investigate the effects of maternal dietary fatty acid composition on metabolic programming of the offspring. We used dietary fatty acids which reflect current intake and recommendations: a high-18 : 2n-6 diet (LA diet), a diet rich in 18 : 3n-3 (ALA diet), a diet high in long-chain n-3 PUFA (FO diet) and an enriched TFA diet. We measured glucose tolerance, insulin sensitivity, lipid metabolism and expression of genes associated with insulin sensitivity of the offspring of dams fed different diets.
Materials and methods
Animals, diet and experimental design
All the procedures involved in animal experiments were conducted in accordance with the guidelines of the institutional animal ethical committee. Sixteen male and thirty-two female Wistar/NIN rats, aged 3 weeks, were obtained from the National Centre for Laboratory Animal Sciences (Hyderabad, India). The animals were housed individually in polypropylene cages at 21 ± 1°C with a 12 h light–dark cycle and fed a cereal–pulse-based diet (Table 1). In male rats groundnut oil was the source of added fat. The female rats were randomly divided into four groups; the added fat source was from various oil blends. The diet provided (by energy) 59 % carbohydrates, 20 % protein and 21 % fat. The added fat components of the diet comprised either 45 % safflower-seed oil and 55 % palm oil (LA diet), 30 % groundnut oil, 30 % palm oil and 40 % linseed oil (ALA diet), 40 % groundnut oil, 50 % palm oil and 10 % fish oil (FO diet) or 50 % safflower-seed oil and 50 % partially hydrogenated vegetable oil (TFA diet). These oil blends were designed so that the fatty acids from both added oils (vegetable oils, FO and/or partially hydrogenated vegetable oil) and fat from components other than added fats (endogenous fat) together furnished different ratios of 18 : 2n-6:18 : 3n-3 (LA group about 28 and ALA group about 2·5), 18 : 2n-6:18 : 3n-3+ long-chain n-3 PUFA (FO group about 10) or 18 : 2n-6:18 : 3n-3 (TFA group 28 plus TFA). The fatty acid compositions of the diets (Table 2) were determined by GC as described earlier(Reference Ghafoorunissa, Reddy and Sesikaran27). Diets were prepared once weekly by adding the oils to the base mixture containing other nutrients (Table 1) and stored at 4°C before use. The oils and base mixtures were stored at 4°C until preparation of the diet. FO was kept under an atmosphere of N2 and stored at − 20°C. All the diets were supplemented with α-tocopherol (0·015 g/kg diet) to prevent oxidation. Rats were given fresh diet every day and had free access to food and water. The daily food intake and weekly body weight of individual rats were recorded.
* All the experimental diets (linoleic acid diet, α-linolenic acid diet, fish oil diet and trans-fatty acid diet) were identical except for the type of fat.
† Salt mixture contained (g/100 g): CaCO3, 3·81; KH2PO4, 3·59; NaCl, 13·93; MgSO4.7H2O, 5·73; MnSO4.H2O, 0·4; KI, 0·8; ZnSO4, 0·48; CuSO4.5H2O, 0·048; CoCl2.6H2O, 0·002; FeSO4.7H2O, 2·2; Na2SeO3, 0·001; (NH4)6MO7O24·4H2O, 0·0008; made up to 100 g with starch.
‡ Vitamin mixture contained (g/100 g): inositol, 2; p-amino benzoic acid, 2; thiamin, 0·05; riboflavin, 0·08; niacin, 0·2; menadione, 0·03; pyridoxine, 0·12; folic acid, 0·02; calcium pantothenate, 0·24; cyanacobalamin, 0·0003; biotin, 0·008; vitamin E acetate, 1·2; made up to 100 g with starch.
LA, linoleic acid; ALA, α-linolenic acid; FO, fish oil; TFA, trans-fatty acid.
After 90 d feeding with the above diets, blood was collected from the retro-orbital sinus in EDTA tubes after overnight fasting and plasma was separated and stored at − 70°C for the analysis of glucose, insulin, TAG and cholesterol. After 5 d of bleeding, the rats were mated with males (two females + one male) and the pregnant rats continued to consume their respective diets throughout gestation. After delivery, the litter weight and size for each mother were recorded. The litter size of each mother was equalised to eight and the mother was continued on the respective experimental diets. At weaning (at age 21 d), only male pups born to LA-group mothers were randomly split into three groups. One group was continued on the LA diet (LA-LA); the other two groups were switched to the ALA diet (LA-ALA) or the FO diet (LA-FO). Pups born to the ALA group (ALA-ALA) and the FO group (FO-FO) were continued on the respective mother's diet. Pups born to TFA mothers were split into two groups. One group was continued on the TFA diet (TFA-TFA) and the other group (TFA-LA) was switched on to the LA diet. Since female sex hormones may have a protective role against the development of insulin resistance, only male pups were studied(Reference Sugden and Holness28, Reference Galipeau, Verma and McNeill29). Fig. 1 gives the schematic representation of the feeding protocol used.
Biochemical methods
The oral glucose tolerance test was done at the end of 90 d feeding of the experimental diets to the pups. Pups were given d-glucose (3 g glucose/kg body weight) through gastric administration after being deprived of food for 18 h. Blood was collected from the retro-orbital sinus in EDTA tubes at 0, 30, 60 and 120 min. Plasma was separated and stored at − 70°C until analysis. Areas under the curve for glucose and insulin were calculated by the trapezoidal rule. Fasting plasma glucose (glucose oxidase/peroxidase kit), TAG (glycerol phosphate oxidase kit) and total cholesterol (cholesterol oxidase-peroxidase kit) were measured using enzymic kits from Biosystems (Barcelona, Spain). Plasma NEFA were measured using an acyl CoA synthetase-oxidase-peroxidase kit from Roche (Basel, Switzerland) and plasma insulin by a RIA kit from BRIT (Board of Radiation & Isotope Technology, Mumbai, India).
At the end of the experimental period (105 d), the animals were killed by CO2 asphyxiation. Epididymal and retroperitoneal fat pads and diaphragm were dissected, weighed and snap-frozen in liquid N2 and stored at − 70°C. A part of epididymal adipose tissue was used for isolation of adipocytes by the collagenase digestion method(Reference Ghafoorunissa, Ibrahim and Natarajan21).
Adipocyte lipolysis was assayed by measuring glycerol release into the incubation medium(Reference Ghafoorunissa, Ibrahim and Natarajan21, Reference Ghafoorunissa, Ibrahim and Rajkumar22). Adipocytes were incubated at 37°C for 2 h in Krebs–Ringer–HEPES (KRH) buffer (pH 7·4) in a final volume of 0·5 ml. Basal lipolysis was measured without the addition of hormone. Hormone-stimulated lipolysis was assessed by adding various concentrations of noradrenaline. The antilipolytic effect of insulin was assessed by incubating adipocytes with 1 μm-noradrenaline (maximum stimulating concentration) and various concentrations of insulin. After 2 h of incubation the cells were separated from the medium by brief centrifugation. The infranatant fraction below the cell layer was removed and glycerol content was estimated.
Basal and insulin-stimulated glucose transport was measured as described(Reference Ghafoorunissa, Ibrahim and Natarajan21, Reference Ghafoorunissa, Ibrahim and Rajkumar22). Adipocytes were pre-incubated with and without various concentrations of porcine insulin at 37°C for 45 min. The cells were incubated with 2-[1,2-3H]deoxyglucose at a concentration of 0·1 mm in KRH buffer (pH 7·4). The assay was terminated at the end of 3 min by transferring the assay mixture to a microcentrifuge tube containing silicone oil. The tube was centrifuged at 4000 rpm for 3 min. The top layer containing adipocytes was transferred to a liquid scintillation vial and radioactivity associated with the adipocytes was measured in a liquid scintillation counter. All data were corrected for non-specific transport by measuring glucose transport in the presence of 0·3 mm-phloretin.
Diaphragm total lipids were extracted using the method of Folch(Reference Folch, Lees and Sloane Stanley30). Neutral lipids were separated from phospholipids by TLC on silica gel G with hexane–diethyl ether–acetic acid (80:20:1, by vol.) and the fatty acid methyl esters were analysed by GC using an SP-2330 capillary column (30 m × 0·25 mm; Supelco, Bellefonte, PA, USA) as described earlier(Reference Ghafoorunissa, Reddy and Sesikaran27).
RNA extraction and reverse transcriptase polymerase chain reaction
Total RNA was isolated from epididymal adipose tissue using TRI reagent (Sigma, St Louis, MO, USA) according to the manufacturer's instructions. Adipose tissue from two rats in each group was pooled for the extraction of RNA. RT-PCR was performed using a single tube access RT-PCR kit (Promega, Madison, WI, USA). The method couples reverse transcription (RT) of total RNA with PCR amplification using gene-specific primers, in the presence of avian myeloblastosis virus (AMV) RT and Thermus filiformis (Tfl) DNA polymerase respectively. Primer sequences were (forward and reverse): rat adiponectin, 5′-aggatccatgctactgttgcaagcgctc-3′ and 5′-gaagcttgttggtatcatggtagagaagg-3′; rat lipoprotein lipase, 5′-gtatcgggcccagcaacattatcc-3′ and 5′-gccttgctggggttttcttcattc-3′; rat GLUT-4, 5′-tctcggtgctcttagtag-3′ and 5′-ccaatctcaaagaaggccacaaa-3′; rat sterol regulatory binding protein-1c, 5′-cgctaccgttcctctatcaatg-3′ and 5′-cctcctccactgccacaag-3′; rat TNF-α, 5′-ctcagcctcttctcattc-3′ and 5′-gaacctgggagtagataag-3′; rat β-actin (internal control), 5′-gtgggccgctctaggcacca-3′ and 5′-cggttggccttagggttcaggggg-3′. The thermal cycler conditions for PCR (thirty cycles) were as follows: initial RT for 10 min at 25°C followed by stringent RT at 48°C for 45 min; inactivation of RT at 95°C for 5 min; denaturation at 94°C for 30 s; annealing at 55–58°C for 30 s; extension at 68°C for 30 s followed by a final extension at 68°C for 7 min. PCR-amplified DNA was electrophoresed on agarose gel (1·5 %) and ethidium bromide-stained bands were analysed densitometrically using the Quantity One software program (version 4.4.0; Bio-Rad, Hercules, CA, USA). Each RT-PCR experiment of individual genes was repeated at least three times. The relative mRNA expression of individual genes was calculated according to the β-actin levels (internal control). The percentage relative expression of candidate genes in different experimental groups was calculated by considering gene expression observed in the LA-LA group as 100.
Statistical analysis
Statistical analysis was done using the SPSS statistical program (SPSS, Inc, Chicago, IL, USA). All of the values are presented as mean values with their standard errors. Data were evaluated by one-way ANOVA followed by least square difference (LSD) post hoc tests. Differences of P < 0·05 were considered significant.
Results
Food intake, body weight, plasma lipids, glucose and insulin
Body weight, food intake, plasma glucose, insulin and lipids of the dams were similar between the groups before and after pregnancy and lactation (data not shown). The litter weight and size were also similar in all groups (data not shown). At weaning and in the post-weaning period up to 105 d, the body weight of the offspring in all the groups was not significantly different (Table 3). At 90 d, plasma glucose, insulin, area under the curve of glucose and area under the curve of insulin after the oral glucose load were not significantly different between the groups. Plasma TAG levels were significantly lower in the LA-ALA group compared with the other groups. The TFA-TFA group had higher plasma cholesterol and NEFA levels compared with the LA-LA group. Plasma levels of cholesterol and NEFA tended to be higher even after switching over the offspring to the LA diet after weaning (TFA-LA).
LA, linoleic acid; ALA, α-linolenic acid; FO, fish oil; TFA, trans-fatty acid; AUC, area under the curve.
a,b,c Mean values within a row with unlike superscript letters were significantly different (P < 0·05; one-way ANOVA).
Adipocyte lipolysis, antilipolysis and glucose transport
Adipocyte lipolysis (basal and noradrenaline stimulated) and antilipolytic effects of insulin were similar in all groups (data not shown). Maternal intake of TFA (TFA-TFA) decreased the adipocyte insulin-stimulated glucose transport of the offspring at all the concentrations of insulin and the decrease was significant only at higher concentration. These changes were not corrected even after switching over to the LA diet devoid of TFA (TFA-LA) after weaning (Fig. 2).
Diaphragm fatty acid composition
The data on diaphragm phospholipids fatty acid composition showed no changes in SFA between the groups (Table 4). Maternal or post-weaning intake of ALA or long-chain n-3 PUFA altered the fatty acid composition of the offspring. As expected, the LA-ALA, LA-FO, ALA-ALA and FO-FO groups had higher n-3 PUFA proportions in the diaphragm phospholipids. The n-3 PUFA supplementation (ALA or FO) significantly decreased the levels of long-chain n-6 PUFA with an increase in the levels of long-chain n-3 PUFA (22 : 6n-3). Maternal intake of TFA resulted in incorporation of 18 : 1 trans.
LA, linoleic acid; ALA, α-linolenic acid; FO, fish oil; TFA, trans-fatty acid.
a,b Mean values within a row with unlike superscript letters were significantly different (P < 0·05; one-way ANOVA).
Gene expression studies
Maternal intake of n-3 PUFA (ALA or long-chain n-3 PUFA) did not alter the mRNA expression of genes associated with insulin sensitivity in the offspring (Fig. 3). Maternal intake of dietary TFA (TFA-TFA) decreased the level of adiponectin mRNA expression (about 35 %) as compared with the LA-LA group. Switching over to the LA diet devoid of TFA from weaning (TFA-LA) did not normalise the TFA-induced decrease in adiponectin mRNA expression (Table 5).
LPL, lipoprotein lipase; sterol regulatory binding protein; LA, linoleic acid; ALA, α-linolenic acid; FO, fish oil; TFA, trans-fatty acid.
* Relative mRNA expression was measured in relation to β-actin mRNA levels. Percentage relative expression of all mRNA was calculated considering the relative mRNA expression observed in the LA-LA group as 100.
Discussion
PUFA, particularly n-3 PUFA, have been shown to increase insulin sensitivity in adult animals. Our earlier studies in male rats have shown that substitution of starch with sucrose in casein-based semi-synthetic diets providing 22 en% fat and 0·03 en% ALA induced insulin resistance by decreasing peripheral insulin sensitivity. However, supplementation of either ALA or long-chain n-3 PUFA prevented the sucrose-induced decrease in peripheral insulin sensitivity(Reference Ghafoorunissa, Ibrahim and Natarajan21, Reference Ghafoorunissa, Ibrahim and Rajkumar22). The maternal nutrient composition has been shown to have an impact on the growth and development of the offspring(Reference Holness, Langdown and Sugden3). The potential role of PUFA and TFA has not been fully explored. Maternal supplementation of n-3 PUFA has been shown to decrease growth rate, adipose tissue mass and serum leptin levels in offspring(Reference Korotkova, Gabrielsson and Lönn31). Moreover, maternal intake of n-6 or n-3 PUFA has been shown to alter the insulin sensitivity and blood pressure in 186-d-old male offspring(Reference Korotkova, Gabrielsson and Holmäng32). In the present study, maternal supplementation of PUFA (n-6 or n-3) did not alter the glucose and lipid metabolism of the male offspring up to age 105 d of postnatal life. Several factors such as age and sex have been shown to have major effect on metabolic programming. The lack of effect of PUFA on metabolic programming in the present study could be due to the short duration of the study. Further, the effects in females need to be studied.
Several studies have documented that dietary ALA increases long-chain n-3 PUFA in various tissues in rats(Reference Kim and Choi33, Reference Abedin, Lien and Vingrys34). Further, prenatal deficiency of ALA has been shown to decrease 22 : 6n-3 proportions in the offspring even after repletion of the diet with ALA after weaning(Reference Li, Weisinger and Weisinger35). Down-regulation of Δ6-desaturase has been suggested to be the cause of low levels of 22 : 6n-3. The present study has demonstrated that increasing ALA or long-chain n-3 PUFA elicits beneficial effects with respect to n-3 PUFA status as evidenced by an increase in long-chain n-3 PUFA levels in diaphragm membrane phospholipids.
In recent years, due to changes in dietary patterns, the intake of TFA has increased. TFA are transferred from mother to fetus(Reference Stender and Dyerberg36). Both the fetus and the breast-fed baby are consequently exposed to TFA corresponding to mother's intake. Animal experiments suggest that a high intake of TFA inhibits the formation of long-chain PUFA which are important in fetal and infant growth and in visual and central nervous system development(Reference Mahfouz, Smith and Kummerow37). Recent studies have shown that the mother's intake of TFA is negatively associated with levels of long-chain PUFA in the blood of newborn infant and therefore have suggested the minimisation of intake of TFA during pregnancy(Reference Hornstra38). A high intake of TFA has been shown to decrease long-chain n-3 PUFA levels in the plasma and liver of pregnant and fetal rats(Reference Larqué, Pérez-Llamas and Puerta39). Epidemiological studies show that the risk of the development of type 2 diabetes is associated with TFA intake(Reference Salmerón, Hu and Manson40). More recent long-term studies in monkeys also showed that dietary TFA increases adiposity and decreases insulin sensitivity(Reference Kavanagh, Jones and Sawyer41). Our earlier study showed that a casein-based semi-synthetic diet providing 10 % fat and 3 en% TFA increased plasma TAG and decreased insulin sensitivity in male rats(Reference Natarajan, Ibrahim and Ghafoorunissa23, Reference Ibrahim, Natrajan and Ghafoorunissa24). In the present study, maternal dietary TFA (1 en%) had no effect on plasma glucose, insulin levels or oral glucose tolerance (glucose and insulin areas under the curve) in the offspring until the age of 105 d. In addition, there were no changes in the levels of long-chain PUFA in diaphragm phospholipids. Altered adiposity and lipid metabolism have been suggested to be early changes before the animals become insulin resistant(Reference Smith42). In the present study, maternal dietary TFA altered cholesterol and lipid metabolism as evidenced by increases in plasma cholesterol and NEFA in the offspring; these changes were not reversed even after switching over to the TFA-free diet from weaning. Recent studies indicate that adipose tissue secretes a number of proteins called adipocytokines which play a major role in whole-body insulin sensitivity(Reference Pittas, Joseph and Greenberg43). Leptin and adiponectin increase insulin sensitivity whereas TNF-α and resistin decrease insulin sensitivity. Dietary SFA and TFA have been shown to differentially alter the adipose tissue expression of genes associated with insulin sensitivity in rats(Reference Saravanan, Haseeb and Ehtesham44). In the present study we also measured the expression levels of some of the genes associated with glucose and lipid metabolism in adipose tissue and also insulin-stimulated glucose transport. Interestingly, maternal dietary TFA down-regulated the expression of adiponectin and decreased insulin-stimulated glucose transport in the offspring; these changes were not reversible even if the offspring were switched over to the TFA-free diet from weaning. These observations suggested the programming effect of the TFA diet. In line with these results, a recent study showed that intra-uterine/prenatal exposure of dietary TFA programmed the hypothalamus feeding control mechanism(Reference Albuquerque, Sardinha and Telles45). Despite alterations in glucose transport, the expression of adipocyte GLUT-4 was not altered in the present study. Membrane lipid composition and fluidity has been shown to play a major role in glucose transport(Reference Sandra, Fyler and Marshall46, Reference Spector and Yorek47). Although we did not measure the adipocyte membrane fluidity, the decrease in glucose transport may be due to changes in membrane fluidity and defective translocation of GLUT-4 to the adipocyte plasma membrane.
In conclusion, the results of the present study indicate that maternal diets high in n-6 PUFA (about 10 en%) or n-3 PUFA (ALA about 3 en%, or about 0·5 en% long-chain n-3 PUFA) did not alter insulin sensitivity of the male offspring at postnatal day 105. However, maternal intake of TFA even at low levels (about 1 en%) evoked programming within the metabolic process of the offspring which may predispose the offspring to the development of insulin resistance in adult life. These findings strengthen the importance of restricting the intake of TFA during pregnancy and lactation.
Acknowledgements
Financial support for the present study was from the National Institute of Nutrition, Hyderabad. India.
A. I. performed the data analysis and drafting of the manuscript; Ghafoorunissa conceived of the study, designed the study, implemented the study, analysed the data and critically revised the manuscript; S. B. performed the gene expression study and drafting of the relevant section of the manuscript; N. Z. E. critically revised the gene expression study section.
The authors thank K. Swarupa Rani, R. Laxmi, A. Vani and A. Brinda for their technical assistance in the care and maintenance of the animals, sample collection and biochemical estimations.
The authors disclose that they have no financial interest or commercial sponsor for the present study.